Nebenwirkungen · Tecvayli
TECVAYLI 10 mg/mL solution for injection TECVAYLI 90 mg/mL solution for injection · Abschnitt 4.8 · PDF-Seite 17–18
HOS-149970 · Präparat HOS-100189
17 Gastrointestinal disorders Diarrhoea14 Very common 45 4.2 Nausea Very common 22 0.4 Constipation Very common 16 0.1 Vomiting Very common 16 0.5 Abdominal pain15 Very common 12 0.5 Musculoskeletal and Musculoskeletal pain16 Very connective tissue disorders common 45 3.4 Muscle spasms Common 6 0 General disorders and Injection site reaction17 Very administration site conditions common 37 0.1 Fatigue18 Very common 37 3.2 Pyrexia Very common 25 0.7 Pain19 Very common 24 0.9 Oedema20 Very common 12 0.3 Investigations Transaminase elevation21 Very common 16 2.8 Weight decreased Very common 13 2 Gamma-glutamyltransferase increased Common 10 2.3 Lipase increased Common 8 1.1
Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.
Vollständigen Kontext in der EMA-Fachinformation lesen →Quellennachweis
Version 2026-08-27T17:12:00Z · SHA-256 f449a9a8542a16a1ef392ed31e9d22089ca7325fcc3f2ef6a0571bfccc1c4da8 · Passage d776236dcf3b17fc96cb5fe64c8555ed3b24ab55c36ebb2b2ab29a3afa4178a4 · Zeichen 7682–9889 im Abschnitt